GlassScriptPhysician profile
Adrianne Bailey
NPI 1073035812
$21,514.89
in general payments reported to CMS, 2019-2025
74 companies · $4,936 in 2025
The $4,936 reported for 2025 was more than what 98% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $3,830 · 2022: $4,280 · 2023: $3,380 · 2024: $5,089 · 2025: $4,936.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Education: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,144.51 |
| Education | $260.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $3,408.66 | 2021-2025 | |
| Biogen, INC. | $1,506.48 | 2021-2025 | Vumerity, Tysabri, Skyclarys |
| Genentech USA, INC. | $1,087.51 | 2021-2025 | Enspryng, Ocrevus, Ocrevus Zunovo |
| Teva Pharmaceuticals USA, INC. | $1,030.07 | 2021-2025 | Austedo Xr, Austedo Xr, Austedo |
| Novartis Pharmaceuticals Corporation | $972.71 | 2021-2025 | |
| Lundbeck LLC | $908.42 | 2021-2025 | Vyepti, Rexulti |
| Ucb, INC. | $884.06 | 2021-2025 | Briviact, Rystiggo |
| Emd Serono, INC. | $822.78 | 2021-2025 | Mavenclad, Mavenclad |
| Celgene Corporation | $517.33 | 2021-2025 | Zeposia |
| Pfizer INC. | $511.26 | 2021-2025 | |
| Acadia Pharmaceuticals INC | $502.10 | 2021-2025 | Nuplazid, Daybue |
| Neurocrine Biosciences, INC. | $480.16 | 2021-2025 | Ingrezza, Ongentys |
| Genzyme Corporation | $462.41 | 2021-2025 | |
| Argenx US, INC. | $447.00 | 2022-2025 | Vyvgart Hytrulo, Vyvgart |
| Lilly USA, LLC | $407.10 | 2021-2025 | Emgality, Amyvid, Reyvow |
Show all 74 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adrianne Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.